Back to search

Article

Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2

2021-04-16

Abstract excerpt

SARS-CoV-2 infection in immunocompromised individuals is associated with prolonged virus shedding and evolution of viral variants. Rapamycin and its analogs (rapalogs, including everolimus, temsirolimus, and ridaforolimus) are FDA-approved as mTOR inhibitors for the treatment of human diseases, including cancer and autoimmunity. Rapalog use is commonly associated with increased susceptibility to infection, which h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
40423237-dfa5-5868-81f5-389d6aab3c58
DOI
10.1101/2021.04.15.440067
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2DOI 10.1101/2021.04.15.440067
Select a neighboring publication to make it the new centre.